C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients

To investigate the expression levels of CXCL10 and CXCR3 in tumors from breast cancer patients randomized to adjuvant tamoxifen treatment or no endocrine treatment, in order to further study the connection to prognosis and prediction of tamoxifen treatment outcome. Immunohistochemistry on tissue mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilborn, Erik, Sivik, Tove, Fornander, Tommy, Stål, Olle, Nordenskjöld, Bo, Jansson, Agneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984417/
https://www.ncbi.nlm.nih.gov/pubmed/24715380
http://dx.doi.org/10.1007/s10549-014-2933-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984417/
https://www.ncbi.nlm.nih.gov/pubmed/24715380
http://dx.doi.org/10.1007/s10549-014-2933-7

Ejemplares similares